The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for stroke: a systematic review and meta-analysis.
<h4>Background</h4>The PlA1/A2 polymorphism of glycoprotein IIIa (GPIIIa) has been reported to be associated with risk of stroke in some studies, although other studies suggest no such association. This meta-analysis and systematic review was conducted to investigate the hypothesis that...
Guardado en:
Autores principales: | Christopher N Floyd, Benjamin H Ellis, Albert Ferro |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a876f7e8f71847bab166a0d6ab6e5a45 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.
por: Christopher N Floyd, et al.
Publicado: (2014) -
Practicability of Bivalirudin plus Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
por: Senjie Li, et al.
Publicado: (2021) -
A young patient with acute myocardial infarction due to bonsai treated with glycoprotein IIbIIIa inhibitor
por: Ömer Doğan, et al.
Publicado: (2021) -
One-Year Outcome of Glycoprotein IIb/IIIa Inhibitor Therapy in Patients with Myocardial Infarction-Related Cardiogenic Shock
por: Krzysztof Myrda, et al.
Publicado: (2021) -
Sensorineural hearing loss and risk of stroke: a systematic review and meta-analysis
por: Masoud Khosravipour, et al.
Publicado: (2021)